The global prosthetic heart valve market is estimated to register a strong CAGR of 12.0% over the forecast period and exceed a market valuation of US$ 19.60 Billion by the end of 2026.
According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures are other factors expected to influence revenue growth of the global prosthetic heart valve market in the next 10 years.
However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.
Request a Sample PDF Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-666
Prosthetic Heart Valve Market Key Segmentation:
By Product Type
- Mechanical Heart Valves
- Mechanical Aortic Valve
- Mechanical Mitral Valve
- Biological/Tissue Heart Valves
- Tissue Aortic Valve
- Tissue Mitral Valve
- Transcatheter Heart Valves
- Transcatheter Aortic Valve
- Transcatheter Mitral Valve
By End User
- Hospitals
- Ambulatory Surgery Centres
By Region
- North America
- Latin America Excluding Brazil
- Brazil
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan (APEJ)
- Middle East & Africa (MEA)
Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-666
Segmental Forecast:
- The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026
- The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015. Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period
Regional Market Overview:
The global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA). The global prosthetic heart valve market is largely prominent in the developed regions.
The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%.
Factors such as legislative openness and inline approval procedures are expected to contribute largely to the revenue generation potential and attractiveness of the Western Europe prosthetic heart valve market. Rising adoption of transcatheter heart valves in geriatric patients for better care is expected to fuel revenue growth in the Japan prosthetic heart valve market over the forecast period.
Competitive Landscape:
The report on the global prosthetic heart valve market profiles some of the leading companies dominating the global prosthetic heart valve market. Top market players featured in the global prosthetic heart valve market report are –
- Edwards Lifesciences Corporation
- St. Jude Medical, Inc.
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- SYMETIS
- LivaNova PLC
- CryoLife, Inc.
- Braile Biomedica
- Colibri Heart Valve LLC
- JenaValve Technology, Inc.
Leading market players are focusing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.
For more Information: https://www.futuremarketinsights.com/reports/prosthetic-heart-valve-market
Key strategies adopted by most of the major players in the global prosthetic heart valve market include: product approvals and commercialization, leveraging existing capabilities to create patient-centric technologies, briskly entering markets in emerging countries and offering the latest innovative technologies to healthcare facilities and, thus strengthening regional proficiency and addressing customer needs. New product launches, innovation and expansion are anticipated to form the core of these strategies during the forecast period.
Top Related Reports Healthcare Market Insights
Transcatheter Heart Valve Replacement (TAVI) Market : is predicted to advance at an impressive CAGR of 12% from 2022 to 2032.
Orthopedic Prosthetic Devices Market : is projected to register a CAGR of 4.7% during the forecast period, up from US$ 1.9 Bn in 2019 to reach a valuation of US$ 2.8 Bn by 2027.
Orthopaedic Prosthetics Market : will witness a CAGR of over 4.5% through 2030.
Glucose Sensor Market : are expected to grow at an 8.6% CAGR between 2022 and 2032, totaling around US$ 16,382 million by the end of 2032.
Retinoids Market : is expected to rise at a healthy CAGR of 5.4% per year to US$ 1.5 billion in 2022.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
The post Overall demand for prosthetic valves is projected to grow at a prolific CAGR of 11.4% totaling US$ 36.3 Bn during the forecast period of 2022-32 | Key data insights by FMI appeared first on Future Market Insights.
